Virt-PN by Virtus Pharmaceuticals — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
72% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size

90 Servings

Multi-Vitamin and Mineral (MVM) Product Type

72% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A

2500 IU (31% DV)

Vitamin C

80 mg (133% DV)

Vitamin D

400 IU (100% DV)

✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)

RDA 0.015mg This product: 0.01mg UL 0.1mg

Vitamin E

10 IU (33% DV)

✅ Within RDA (0.4× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)

RDA 15mg This product: 6.7mg UL 1000mg

Vitamin B1

3 mg (176% DV)

✅ 2.5× RDA — within safe limits 📚 76 studies (Tier A: 0, B: 33)

RDA 1.2mg This product: 3mg

Vitamin B2

3.4 mg (170% DV)

✅ 2.6× RDA — within safe limits 📚 12 studies (Tier A: 0, B: 1)

RDA 1.3mg This product: 3.4mg

Niacinamide

20 mg (100% DV)

✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 20mg UL 35mg

Vitamin B6

20 mg (800% DV)

📊 15.4× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)

RDA 1.3mg This product: 20mg UL 100mg

Folate

1 mg (125% DV)

✅ 2.5× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)

RDA 0.4mg This product: 1mg UL 1.0mg

Vitamin B12

12 mcg (150% DV)

📊 5.0× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)

RDA 0.0024mg This product: 0.012mg

Biotin

300 mcg (100% DV)

📊 10.0× RDA — above typical dose 📚 26 studies (Tier A: 0, B: 11)

RDA 0.03mg This product: 0.3mg

Pantothenic Acid

6 mg (60% DV)

✅ 1.2× RDA — within safe limits 📚 1 studies — no high-quality reviews

RDA 5mg This product: 6mg

Calcium

120 mg (9% DV)

Iron

27 mg (150% DV)

Iodine

150 mcg (100% DV)

✅ Within RDA (1.0× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)

RDA 0.15mg This product: 0.15mg UL 1.1mg

Magnesium

30 mg (7% DV)

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)

This product: 30mg

Zinc

15 mg (100% DV)

✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)

RDA 11mg This product: 15mg UL 40mg

Copper

2 mg (100% DV)

✅ 2.2× RDA — within safe limits 📚 36 studies (Tier A: 0, B: 11)

RDA 0.9mg This product: 2mg UL 10mg

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Stearic Acid Magnesium Stearate Croscarmellose Sodium Silica Polyvinyl Alcohol Hypromellose Titanium Dioxide Talc Polyethylene Glycol

Label Claims — Verification

❓ Nutrient

❓ All Other

All Other (99% of products) Structure/Function (76% of products) Nutrient (58% of products)

Target Groups

Pregnant Women Adult Female (18 - 50 Years) Lactating

Product Information

📋 Directions for Use

Dosage and administration: Before, during and/or after pregnancy, on tablet daily or as directed by a licensed healthcare practitioner regardless of lactation status.

⚠️ Warnings & Precautions

Description: Virt-PN is a prescription prenatal/postnatal multivitamin/mineral dietary supplement and should be administered under the supervision of a licensed medical practitioner.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Caution: High levels of folic acid may, especially in older adults, hide signs of Vitamin B-12 deficiency (such as pernicious anemia), a condition that can cause nerve damage.

Call your licensed medical practitioner about side effects. You may report side effects by calling Virtus at 1-888-848-3593 or FDA at 1-800-FDA-1088.

🧪 Formulation Notes

Prenatal/Postnatal

Prescription Folate-Containing Dietary Supplement

Additional Information

69543-241-90

Rx Made in USA

Store at 20(0) - 25(0)C (68(0) - 77(0)F). Excursions permitted to 15(0) to 30(0)C (59(0) to 86(0)F). [See USP Controlled Room Temperature.] Protect from light and moisture. Dispense in a tight, light-resistant container. Notice: Contact with moisture may produce surface discoloration or erosion.

How supplied: Supplied as oblong, white tablet imprinted "V241" dispensed in bottles of 90 tablets.

Rev. 03/15

Product Details

UPC / SKU 3 69543 24190 6

DSLD Entry Date 2018-08-31

Product Type Multi-Vitamin and Mineral (MVM)

Form Tablet or Pill

Brand Virtus Pharmaceuticals

DSLD ID 180521

Data Updated 2026-04-11

Research Evidence

337 Research Sources

54 Avg Quality Score

161 Meta Analysis

68 Systematic Review

51 Rct

48 Clinical Trial

2 Other

2 Regulatory Source

1 Narrative Review

1 Cochrane Review

1 Guideline

1 Openfda Safety

A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

Meta Analysis BMJ (Clinical research ed.) 2011

PubMed DOI

A Fortification of staple foods with vitamin A for vitamin A deficiency

Systematic Review The Cochrane database of systematic reviews 2019

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age

Narrative Review The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Meta Analysis Journal of sport and health science 2023

PubMed DOI

A Food fortification with multiple micronutrients: impact on health outcomes in general population

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age

Meta Analysis The Cochrane database of systematic reviews 2024

PubMed DOI

View all evidence for Vitamin A →